VitaNova Life Sciences (VNOV) Other Non Operating Income (2021 - 2026)

VitaNova Life Sciences (VNOV) has 4 years of Other Non Operating Income data on file, last reported at -$3271.0 in Q2 2026.

• Quarterly Other Non Operating Income changed N/A year-over-year to -$3271.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$3151.0 (down 735.28% YoY) and the FY2026 annual result came in at -$3151.0, down 735.28% from the prior year.
• Other Non Operating Income retreated to -$3271.0 in Q2 2026, from $120.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $300.0 in Q4 2024 to a low of -$3271.0 in Q2 2026.
• A 3-year average of -$510.0 and a median of $120.0 in 2025 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 60.0% in 2025, down 60.0% in 2025.
• Tracing VNOV's Other Non Operating Income over 3 years: stood at $300.0 in 2024, then slumped by 60.0% to $120.0 in 2025, then tumbled by 2825.83% to -$3271.0 in 2026.
• The last three Other Non Operating Income figures came in at -$3271.0 (Q2 2026), $120.0 (Q4 2025), and $196.0 (Q1 2025), per Business Quant data.